-+ 0.00%
-+ 0.00%
-+ 0.00%

PTC Therapeutics director Glenn Steele Jr reports sale of 12,000 common shares worth $781,920

PUBT·10/02/2026 21:22:03
PTC Therapeutics director Glenn Steele Jr reports sale of 12,000 common shares worth $781,920
  • PTC Therapeutics director Glenn Steele Jr. reported selling 12,000 common shares at USD 65.16 on Sept. 30, 2026.
  • He exercised stock options for 12,000 shares at USD 11.23 the same day.
  • Directly held common shares totaled 22,500 following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PTC Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001269131-26-000005), on October 02, 2026, and is solely responsible for the information contained therein.